Related Experiment Video
Updated: May 7, 2026

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
Determinants of 14-3-3σ protein dimerization and function in drug and radiation resistance
1From the Department of Pharmacology and Toxicology and.
Abstract:
Many proteins exist and function as homodimers. Understanding the detailed mechanism driving the homodimerization is important and will impact future studies targeting the "undruggable" oncogenic protein dimers. In this study, we used 14-3-3σ as a model homodimeric protein and performed a systematic investigation of the potential roles of amino acid residues in the interface for homodimerization. Unlike other members of the conserved 14-3-3 protein family, 14-3-3σ prefers to form a homodimer with two subareas in the dimeric interface that has 180° symmetry. We found that both subareas of the dimeric interface are required to maintain full dimerization activity. Although the interfacial hydrophobic core residues Leu(12) and Tyr(84) play important roles in 14-3-3σ dimerization, the non-core residue Phe(25) appears to be more important in controlling 14-3-3σ dimerization activity. Interestingly, a similar non-core residue (Val(81)) is less important than Phe(25) in contributing to 14-3-3σ dimerization. Furthermore, dissociating dimeric 14-3-3σ into monomers by mutating the Leu(12), Phe(25), or Tyr(84) dimerization residue individually diminished the function of 14-3-3σ in resisting drug-induced apoptosis and in arresting cells at G2/M phase in response to DNA-damaging treatment. Thus, dimerization appears to be required for the function of 14-3-3σ.
Insights
Protein homodimerization is crucial for function. This study reveals key residues driving 14-3-3σ homodimer formation, essential for its role in resisting apoptosis and cell cycle arrest.
Area of Science:
- Molecular Biology
- Protein Structure and Function
- Biochemistry
Background:
- Many proteins function as homodimers, making their assembly mechanisms critical for biological processes.
- Targeting oncogenic protein dimers is a key strategy in cancer therapy, necessitating a deep understanding of dimerization.
- 14-3-3 proteins are a conserved family involved in various cellular signaling pathways.
Purpose of the Study:
- To systematically investigate the role of amino acid residues in the homodimerization interface of 14-3-3σ.
- To identify key residues that control the dimerization activity and stability of 14-3-3σ.
- To determine the functional significance of 14-3-3σ dimerization in cellular responses.
Main Methods:
- Site-directed mutagenesis of specific amino acid residues within the 14-3-3σ homodimer interface.
- Assays to measure protein dimerization activity and stability.
- Functional assays assessing 14-3-3σ's role in apoptosis resistance and cell cycle arrest.
Main Results:
- 14-3-3σ forms a homodimer with two distinct subareas in its interface, exhibiting 180° symmetry.
- Both interfacial subareas are essential for maintaining full dimerization activity.
- While core residues Leu(12) and Tyr(84) are important, non-core residue Phe(25) plays a more critical role in 14-3-3σ dimerization.
- Mutations disrupting dimerization of 14-3-3σ abolished its ability to resist drug-induced apoptosis and arrest cells at G2/M phase.
Conclusions:
- 14-3-3σ dimerization involves specific interfacial regions and key residues, with non-core residues like Phe(25) being particularly influential.
- Protein homodimerization is essential for the biological functions of 14-3-3σ, including its roles in cell survival and DNA damage response.
- Understanding these dimerization mechanisms provides insights for developing targeted therapies against oncogenic protein dimers.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Single-Strand DNA Binding Proteins
Abnormal Proliferation

